Mechanism of action of venetoclax (ABT-199) and its side effects
Can ibrutinib be used as a first-line treatment in CLL?
Why is personalized medicine important for CLL?
Looking beyond the leukemic cell for answers
Christopher Pepper et al.
Current research into drug treatments for CLL - specifically ibrutinib, idelalisib and venetoclax